These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9793067)

  • 1. [Adrenomedullin and related peptides].
    Kitamura K
    Nihon Yakurigaku Zasshi; 1998 Sep; 112(3):137-46. PubMed ID: 9793067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adrenomedullin and PAMP].
    Kitamura K; Eto T
    Nihon Rinsho; 1997 Aug; 55(8):1963-70. PubMed ID: 9284408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenomedullin: a new modulator of vascular tone.
    Kangawa K; Kitamura K; Minamino N; Matsuo H
    J Card Fail; 1996 Dec; 2(4 Suppl):S135-40. PubMed ID: 8951571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenomedullin: a new hypotensive peptide.
    Kangawa K; Kitamura K; Minamino N; Eto T; Matsuo H
    J Hypertens Suppl; 1996 Dec; 14(5):S105-10. PubMed ID: 9120666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides.
    Eto T
    Peptides; 2001 Nov; 22(11):1693-711. PubMed ID: 11754955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels.
    Etoh T; Kato J; Takenaga M; Imamura T; Kitamura K; Koiwaya Y; Eto T
    Clin Cardiol; 1999 Feb; 22(2):113-7. PubMed ID: 10068849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions.
    Kitamura K; Kangawa K; Eto T
    Microsc Res Tech; 2002 Apr; 57(1):3-13. PubMed ID: 11921351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenomedullin--physiological regulator of the cardiovascular system or biochemical curiosity?
    Kitamura K; Eto T
    Curr Opin Nephrol Hypertens; 1997 Jan; 6(1):80-7. PubMed ID: 9051359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.
    Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
    Kitamura K; Kangawa K; Kawamoto M; Ichiki Y; Nakamura S; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1993 Apr; 192(2):553-60. PubMed ID: 8387282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proadrenomedullin-derived peptides.
    Samson WK
    Front Neuroendocrinol; 1998 Apr; 19(2):100-27. PubMed ID: 9578982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats.
    Samson WK; Murphy TC; Resch ZT
    Am J Physiol; 1998 May; 274(5):R1505-9. PubMed ID: 9612421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bronchodilator responses to adrenomedullin and proadrenomedullin N-terminal 20 peptide.
    Kanazawa H; Kawaguchi T; Fujii T; Kudoh S; Hirata K; Kurihara N; Takeda T
    Life Sci; 1995; 57(16):PL241-5. PubMed ID: 7564889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide.
    Shimosawa T; Fujita T
    Hypertension; 1996 Sep; 28(3):325-9. PubMed ID: 8794811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin and proadrenomudullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect.
    Marutsuka K; Nawa Y; Asada Y; Hara S; Kitamura K; Eto T; Sumiyoshi A
    Exp Physiol; 2001 Sep; 86(5):543-5. PubMed ID: 11571480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin and diabetes mellitus.
    Ruzicska E; Toth M; Tulassay Z; Somogyi A
    Diabetes Metab Res Rev; 2001; 17(5):321-9. PubMed ID: 11747138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of PAMP-12 (PAMP[9-20]) in porcine adrenal medulla as a major endogenous biologically active peptide.
    Kuwasako K; Kitamura K; Ishiyama Y; Washimine H; Kato J; Kangawa K; Eto T
    FEBS Lett; 1997 Sep; 414(1):105-10. PubMed ID: 9305741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution and molecular forms of adrenomedullin and proadrenomedullin N-terminal 20 peptide in the porcine gastrointestinal tract.
    Kiyomizu A; Kitamura K; Kawamoto M; Eto T
    J Gastroenterol; 2001 Jan; 36(1):18-23. PubMed ID: 11211206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings.
    Shimosawa T; Ito Y; Ando K; Kitamura K; Kangawa K; Fujita T
    J Clin Invest; 1995 Sep; 96(3):1672-6. PubMed ID: 7657838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracrine effects of PAMP and adrenomedullin on the human adrenal H295R cell line: PAMP but not adrenomedullin stimulates DHEA secretion.
    Thomson LM; Kapas S; Hinson JP
    Regul Pept; 2003 Apr; 112(1-3):3-7. PubMed ID: 12667619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.